A carregar...
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As such, there is an urgent need for vaccines and therapeutics to reduce the burden of COVID-19. Several vaccines, including mRNA, vector-based vaccines, and inactivated vaccines, have been approved for emergency...
Na minha lista:
| Publicado no: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043070/ https://ncbi.nlm.nih.gov/pubmed/33859652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.663586 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|